180 related articles for article (PubMed ID: 21861150)
21. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
22. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
23. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
[TBL] [Abstract][Full Text] [Related]
24. [Improved prognostic assessment of head-neck carcinomas by new genetic markers].
Bockmühl U; Küchler I; Petersen I
HNO; 2000 Jun; 48(6):451-6. PubMed ID: 10929226
[TBL] [Abstract][Full Text] [Related]
25. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
26. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.
Prigge ES; Toth C; Dyckhoff G; Wagner S; Müller F; Wittekindt C; Freier K; Plinkert P; Hoffmann J; Vinokurova S; Klussmann JP; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2015 Apr; 136(7):1589-99. PubMed ID: 25104331
[TBL] [Abstract][Full Text] [Related]
27. [Translational approaches in cancer stem cell research].
Mozet C; Wichmann G; Dietz A
HNO; 2011 Sep; 59(9):859-65. PubMed ID: 21847639
[TBL] [Abstract][Full Text] [Related]
28. Histopathologic findings of HPV and p16 positive HNSCC.
Mendelsohn AH; Lai CK; Shintaku IP; Elashoff DA; Dubinett SM; Abemayor E; St John MA
Laryngoscope; 2010 Sep; 120(9):1788-94. PubMed ID: 20803740
[TBL] [Abstract][Full Text] [Related]
29. Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer.
Zhao N; Ang MK; Yin XY; Patel MR; Fritchie K; Thorne L; Muldrew KL; Hayward MC; Sun W; Wilkerson MD; Chera BS; Hackman T; Zanation AM; Grilley-Olson JE; Couch ME; Shockley WW; Weissler MC; Shores CG; Funkhouser WK; Olshan AF; Hayes DN
Br J Cancer; 2012 Jul; 107(3):482-90. PubMed ID: 22735904
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors in head-neck carcinomas].
Weber A; Tannapfel A
HNO; 2002 Jan; 50(1):35-42. PubMed ID: 11963785
[TBL] [Abstract][Full Text] [Related]
31. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy.
Ramesh PS; Devegowda D; Singh A; Thimmulappa RK
Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315
[TBL] [Abstract][Full Text] [Related]
32. The role of MAGEA2 in head and neck cancer.
Glazer CA; Smith IM; Bhan S; Sun W; Chang SS; Pattani KM; Westra W; Khan Z; Califano JA
Arch Otolaryngol Head Neck Surg; 2011 Mar; 137(3):286-93. PubMed ID: 21422315
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].
Haas S; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 1999 Sep; 47(9):777-86. PubMed ID: 10525606
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
35. Current potential and limitations of molecular diagnostic methods in head and neck cancer.
Mahfouz ME; Rodrigo JP; Takes RP; Elsheikh MN; Rinaldo A; Brakenhoff RH; Ferlito A
Eur Arch Otorhinolaryngol; 2010 Jun; 267(6):851-60. PubMed ID: 20037788
[TBL] [Abstract][Full Text] [Related]
36. Significance of
DE Jesus Oliveira Kato V; DE Abreu MC; DE Brito Kato AM; DE Souza LL; Pontes FSC; DE Castro Sant'anna C; GonÇalves A; Pontes HAR; Khayat AS; Burbano RMR
Anticancer Res; 2020 Nov; 40(11):6355-6366. PubMed ID: 33109573
[TBL] [Abstract][Full Text] [Related]
37. Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma.
Ralli M; Singh S; Yadav SP; Sharma N; Verma R; Sen R
J Cancer Res Ther; 2016; 12(1):232-7. PubMed ID: 27072243
[TBL] [Abstract][Full Text] [Related]
38. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
[TBL] [Abstract][Full Text] [Related]
39. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
[TBL] [Abstract][Full Text] [Related]
40. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
Dreyer JH; Hauck F; Barros MHM; Niedobitek G
Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]